Cargando…
Digital Microfluidics in Newborn Screening for Mucopolysaccharidoses: A Progress Report
Newborn screening (NBS) for mucopolysaccharidosis type I (MPS I, Hurler syndrome) is currently conducted in about two-fifths of the NBS programs in the United States and in a few other countries. Screening is performed by measurement of residual activity of the enzyme alpha-l-iduronidase in dried bl...
Autores principales: | Washburn, Jon, Millington, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711648/ https://www.ncbi.nlm.nih.gov/pubmed/33124616 http://dx.doi.org/10.3390/ijns6040078 |
Ejemplares similares
-
Newborn screening in mucopolysaccharidoses
por: Donati, Maria Alice, et al.
Publicado: (2018) -
Correction to: Newborn screening in mucopolysaccharidoses
por: Donati, Maria Alice, et al.
Publicado: (2019) -
Emerging Approaches for Fluorescence-Based Newborn Screening of Mucopolysaccharidoses
por: Singh, Rajendra, et al.
Publicado: (2020) -
Newborn screening for mucopolysaccharidoses: Measurement of glycosaminoglycans by LC-MS/MS
por: Stapleton, Molly, et al.
Publicado: (2020) -
Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan
por: Chuang, Chih-Kuang, et al.
Publicado: (2018)